Position in VKTX
as of Mar 31, 2026
· filed May 15, 2026
Position Value
$4,083,314
-$343,279 QoQ
Shares Held
125,486
-0.3% QoQ
Ownership
0.108%
of shares outstanding
% of Portfolio
0.01%
of 13F equity value
Holder Rank
—
not a current holder
Holding Since
Dec 2023
10 quarters on record
Voting authority
Sole 0%
Shared 100%
None 0%
Common Shares in VKTX Over Time
Shares Held
Position Value (USD)
Position in Biotechnology
Healthcare · as of Jun 30, 2026BAMCO INC /NY/ holds $406,272,438 across 24 Biotechnology names.
| # | Ticker | Company | Shares | Value (USD) | Open |
|---|---|---|---|---|---|
| 1 | MRNA |
Moderna, Inc.
|
1,989,386 | $139,316,701 | |
| 2 | ARGX |
Argenx SE
|
136,654 | $126,783,481 | |
| 3 | ARQT |
Arcutis Biotherapeutics, Inc.
|
1,253,120 | $32,856,806 | |
| 4 | ZLAB |
Zai Lab Ltd
|
1,623,694 | $30,850,186 | |
| 5 | MANE |
Veradermics, Inc
|
229,581 | $28,224,688 | |
| 6 | DFTX |
Definium Therapeutics, Inc.
|
520,108 | $24,465,880 | |
| 7 | ROIV |
Roivant Sciences Ltd.
|
125,000 | $4,423,750 | |
| 8 | VRTX |
Vertex Pharmaceuticals Inc / Ma
|
6,000 | $2,980,380 |
All Filings in VKTX
Export CSV
10 filing rows on record
| Report Date | Value (USD) | Shares | Type | Discretion | Filed | |
|---|---|---|---|---|---|---|
| 2026-03-31 | $4,083,314 | 125,486 | Shares | Defined | 2026-05-15 | |
| 2025-12-31 | $4,426,593 | 125,827 | Shares | Defined | 2026-02-17 | |
| 2025-09-30 | $3,330,648 | 126,737 | Shares | Defined | 2025-11-14 | |
| 2025-06-30 | $3,358,530 | 126,737 | Shares | Defined | 2025-08-14 | |
| 2025-03-31 | $9,713,299 | 402,207 | Shares | Defined | 2025-05-15 | |
| 2024-12-31 | $15,511,393 | 385,472 | Shares | Defined | 2025-02-14 | |
| 2024-09-30 | $30,049,711 | 474,644 | Shares | Defined | 2024-11-14 | |
| 2024-06-30 | $26,654,435 | 502,819 | Shares | Defined | 2024-08-14 | |
| 2024-03-31 | $40,447,238 | 493,259 | Shares | Defined | 2024-05-15 | |
| 2023-12-31 | $5,770,346 | 310,067 | Shares | Defined | 2024-02-14 | |
| No filing history on record for this holder in this stock. | ||||||